Release Date: April 30, 2019 Expiration Date: April 30, 2020 (subject to change)
CE for this activity will not be available after this date.
Overview Many patients with plaque psoriasis experience negative health consequences that could be prevented or improved with optimal evidence-based care. This activity will address management of plaque psoriasis, including establishing treatment targets and tailoring treatment, as well as addressing comorbid conditions and engaging with patients to improve treatment satisfaction and adherence.
It also provides the opportunity for those who complete the program to pose questions for faculty in an “Ask the Expert” feature!CE Credit Instructions
Read this activity description, including objectives and disclosures.
Complete the educational content completely:
Video Presentations: Watch all video presentations completely.
Review all additional materials provided (handouts, posttest reviews, all other downloadable resources).
After completing all content, go to Steps to Receive Credit:
Complete the activity posttest.
Complete the activity evaluation.
60 days after completion the learner will receive an invitation to an optional Post Impact Survey for this activity.
Objectives Upon completion of this presentation, the learner will be able to:
Screen patients diagnosed with plaque psoriasis for depression, anxiety, and other common comorbid conditions.
Review treatment options and create individualized plaque psoriasis management plans based on severity and comorbidities using shared decision--making model.
Faculty Peggy Vernon, RN, MA, CPNP, DCNP, FAANP Lakshi Aldredge MSN, ANP-BC, DCNPDisclosure This activity was planned in accordance with AANP Accreditation Standards and Policies and has been created in collaboration with MCM Education. This activity is supported by independent educational grants from Novartis, AbbVie, and Celgene.
Lakshi Aldredge discloses that she has served on speakers’ bureaus and as a consultant for AbbVie, Celgene, Lilly, Novartis, Regeneron/Sanofi-Genzyme, and Sun Pharma. Peggy Vernon has no potential conflicts of interest to disclose.
This educational activity may contain opinions of the speakers from their personal experience. The activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings. Further, attendees/participants should appraise the information presented critically and are encouraged to consult appropriate resources for any product or device mentioned in this program.Additional Information For questions about this online CE activity, or more information concerning the AANP CE Center, contact the AANP CE Center Manager at CECenter@aanp.org.
0.5 Contact Hour(s) of CE, All of which may be applied towards Pharmacology
Additional CE activities of interest
(OnDemand) Improving Outcomes in Plaque Psoriasis: The Role of the Nurse Practitioner, Activity A-Pathogenesis and Diagnosis